Register now Contact us

CME Overview

Evaluations and CME Certificates

Online evaluations will be available through June 15, 2022 (please email evals@HealioLive.com if you need assistance this year or with obtaining a certificate from a previous year.

Target Audience

This educational activity is designated for AMA PRA Category 1 Credit(s)™ for all US physicians. US physicians will receive a CME certificate and non-US physicians should contact their respective organizations for reciprocity of credit.

Target Audience

Attendance is open to all retina specialists and any other healthcare providers who are interested in participating in a global scientific and clinical exchange on advances in retinal health.

Program Summary

Retina World Congress is a non-profit organization dedicated to uniting international professionals to foster dialogue and to generate consensus about retinal diseases, emerging technologies and treatments, best practices and clinical research. The belief is that we can foster more collaboration between national and regional retinal societies, providing a single focal point of information exchange for the global retina community. Our annual meeting offers attendees an extraordinary program created by and for retina specialists from around the globe and successfully brings together 100+ faculty and hundreds of attendees from 35+ U.S. states, 50+ countries and 40+ international retina societies.

Learning Objectives: General Sessions

Upon completion of this activity, attendees will have better knowledge of the following subject matters:

  • Review the latest evidence, clinical trial data, and treatment options for various retinal disorders and inherited retinal diseases.
  • Identify new advances in surgical technology that can improve outcomes in patients with retinal diseases and disorders.
  • Describe the latest surgical procedures in vitrectomy that can improve patient outcomes.
  • Explore the use of gene and cell therapy in the management of inherited, as well as non-inherited retinal diseases.
  • Evaluate new imaging and artificial intelligence modalities that can improve retinal disease detection and better assess patient responses to therapy.
  • Recognize new advances in the management of neovascular, as well as dry age-related macular degeneration (AMD), and geographic atrophy.
  • Detail the use of vitrectomy and other surgical advances in the treatment of diabetic retinopathy (DR).
  • Assess novel management strategies in retinal detachment surgery including the use of vitrectomy, air, and multimodal imaging, as well as and other techniques and technology.
  • Describe the latest clinical trial data, patient outcomes, and emerging medical treatments for diabetic macular edema (DME) and diabetic retinopathy (DR).
  • Examine reconstructive and surgical techniques used in trauma and proliferative vitreoretinopathy surgery.
  • Recognize controversies in the management of retinal diseases including the treatment of neovascular AMD, geographic atrophy, and the use of scleral buckling in retinal detachment surgery.
  • Explore new practices and procedures that can improve the overall management of infectious, non-infectious, and drug-induced uveitis.
  • Evaluate key information regarding front-line therapies, novel drug delivery, new treatments, and the use of vitrectomy in patients with uveitis.
  • Assess macular surgery procedures and techniques that can optimize the management of macular hole, myopic traction maculopathy, and autologous retinal transplant.
  • Examine challenging medical and surgical case presentations in patients with retinal diseases and their appropriate management.
  • Assess the use of medical and surgical therapies for pediatric patients with inherited and non-inherited retinal diseases and disorders.
  • Analyze new developments in ocular oncology, along with their appropriate diagnosis and management.

This continuing education activity is provided by

Official media partnership with

Official Journal

ACCREDITATION: In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CREDIT DESIGNATION: Vindico Medical Education designates this live activity for 23.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

INTERNATIONAL NOTICE: This educational activity is designated for AMA PRA Category 1 Credit(s)™ for all US physicians. US physicians will receive a CME certificate and non-US physicians should contact their respective organizations for reciprocity of credit.

FACULTY/PLANNER DISCLOSURE POLICY: Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest will be mitigated prior to the commencement of the activity.

All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational uses of any products/devices.

NOTICE: Faculty, topics, program schedule and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program director and the Office of Medical Affairs and Compliance.